Caracterización antigénica de cepas colombianas del Virus del Distemper Canino (CDV) para el desarrollo biotecnológico y validación in vivo de vacuna de nueva generación

Santiago Rendón-Marín; Francisco Javier Díaz; Julián Ruíz-Saenz

doi:10.17533/udea.iatreia.342356

Autores/as

Santiago Rendón-Marín Universidad Cooperativa de Colombia, Universidad de Antioquia https://orcid.org/0000-0001-8210-9306
Francisco Javier Díaz Universidad de Antioquia https://orcid.org/0000-0003-3352-3652
Julián Ruíz-Saenz Universidad Cooperativa de Colombia https://orcid.org/0000-0002-1447-1458

DOI:

https://doi.org/10.17533/udea.iatreia.342356

|Resumen

= 836 veces | PDF

= 434 veces|

Descargas

Los datos de descargas todavía no están disponibles.

Biografía del autor/a

Santiago Rendón-Marín, Universidad Cooperativa de Colombia, Universidad de Antioquia

Grupo de Investigación en Ciencias Animales (GRICA), Facultad de Medicina Veterinaria y Zootecnia. Corporación Académica Ciencias Básicas Biomédicas, Universidad de Antioquia.

Francisco Javier Díaz, Universidad de Antioquia

Grupo Inmunovirología.

Julián Ruíz-Saenz, Universidad Cooperativa de Colombia

Grupo de Investigación en Ciencias Animales (GRICA).

Citas

(1) Buczkowski H, Muniraju M, Parida S, Banyard AC. Morbillivirus vaccines: recent successes and future hopes. Vaccine. 2014;32(26):3155-3161.

(2) Carpenter JW, Appel MJ, Erickson RC, Novilla MN. Fatal vaccine-induced canine distemper virus infection in black-footed ferrets. J Am Vet Med Assoc. 1976;169(9):961-4.

(3) Chinnakannan SK, Nanda SK, Baron MD. Morbillivirus v proteins exhibit multiple mechanisms to block type 1and type 2 interferon signalling pathways. PLoS One. 2013;8(2):e57063.

(4) de Vries RD, Ludlow M, de Jong A, Rennick L, Verburgh RJ, van Amerongen G, et al. Delineating morbillivirus entry, dissemination and airborne transmission by studying in vivo competition of multicolor canine distemper viruses in ferrets. PLoS Pathog. 2017;13(5):e1006371.

(5) Haig DA, Alexander RA, Clark R, Louw JG, de Kock VE. Canine distemper-immunization with avianised virus. Journal of Veterinary Research. 1956;27(1).

(6) Halbrooks RD, Swango LJ, Schnurrenberger PR, Mitchell FE, Hill EP. Response of gray foxes to modified live-virus canine distemper vaccines. J Am Vet Med Assoc. 1981;179(11):1170-4.

(7) Hartley WJ. A post-vaccinal inclusion body encephalitis in dogs. Vet Pathol. 1974;11(4):301-312.

(8) Ke GM, Ho CH, Chiang MJ, Sanno-Duanda B, Cheng-Shu C, Maw-Yeong L,et al. Phylodynamic analysis of the canine distemper virus hemagglutinin gene. BMC Vet Res. 2015;11:164. Published 2015 Jul 25.

(9) MacLachlan N, Dubovi E, Fenner F, editores. Paramyxoviridae. EE. UU: Fenner’s Veterinary Virology;2011.

(10) Martella V, Cirone F, Elia G, Lorusso E, DecaroN, Campolo M, et al. Heterogeneity within the hemagglutinin genes of canine distemper virus (CDV) strains detected in Italy. Vet Microbiol. 2006;116(4):301-309.

(11) Martinez-Gutierrez M, Ruiz-Saenz J. Diversity of susceptible hosts in canine distemper virus infection: a systematic review and data synthesis. BMC Vet Res. 2016;12:78. Published 2016 May 12.

(12) McInnes EF, Burroughs RE, Duncan NM. Possible vaccine-induced canine distemper in a South American bush dog (Speothos venaticus). J Wildl Dis. 1992;28(4):614-617.

(13) Noyce RS, Delpeut S, Richardson CD. Dog nectin-4 is an epithelial cell receptor for canine distemper virus that facilitates virus entry and syncytia formation. Virology. 2013;436(1):210-220.

(14) Pardo MC, Tanner P, Bauman J, Silver K, Fischer L. Immunization of puppies in the presence of maternally derived antibodies against canine distemper virus. J Comp Pathol. 2007;137 Suppl 1:S72-S75.

(15) ROCKBORN G. An attenuated strain of canine distemper virus in tissue culture. Nature. 1959;184(Suppl 11):822.

(16) Schuhmann KM, Pfaller CK, Conzelmann KK. The measles virus V protein binds to p65 (RelA) to suppress NF-kappaB activity. J Virol. 2011;85(7):3162-3171.

(17) Schultz RD. Duration of immunity for canine and feline vaccines: a review. Vet Microbiol. 2006;117(1):75-79.

(18) Stephensen CB, Welter J, Thaker SR, Taylor J, Tartaglia J, Paoletti E. Canine distemper virus (CDV) infection of ferrets as a model for testing Morbillivirus vaccine strategies: NYVAC- and ALVAC-based CDV recombinants protect against symptomatic infection. J Virol. 1997;71(2):1506-13.

(19) Thomas-Baker B. Vaccination-induced distemper in maned wolves, vaccination-induced corneal opacity in a maned wolf. Paper presented at the Proc. Am. Assoc. Zoo Vet. 1985.

(20). von Messling V, Zimmer G, Herrler G, Haas L, Cattaneo R. The hemagglutinin of canine distemper virus determines tropism and cytopathogenicity. J Virol. 2001;75(14):6418-6427.

(21) Wimsatt J, Biggins D, Innes K, Taylor B, Garell D. Evaluation of oral and subcutaneous delivery of an experimental canarypox recombinant canine distemper vaccine in the Siberian polecat (Mustela eversmanni). J Zoo Wildl Med. 2003;34(1):25-35.